发明名称 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
摘要 A method of treating a mammal comprises administering to a mammal an effective amount to provide a desired therapeutic effect in the mammal of a compound selected from the group consisting of those having formula (I), and pharmaceutically acceptable acid addition salts thereof and mixtures thereof, wherein R1 and R2 each is selected from the group consisting of alkyl radicals containing 1 to 4 carbon atoms and alkoxy radicals containing 1 to 4 carbon atoms, the 2-imidazolin-2-ylamino group may be in any of the 5-, 6-, 7- or 8- positions of the quinoxaline nucleus, and R3, R4 and R5 each is located in one of the remaining 5-, 6-, 7- or 8-positions of the quinoxaline nucleus and is independently selected from the group consisting of Cl, Br, H and alkyl radicals containing 1 to 3 carbon atoms. Such compounds, when administered to a mammal, provide desired therapeutic effects, such as reduction in peripheral pain, anesthetization of the central nervous system, constriction of one or more blood vessels, reduction in or prevention of at least one effect of ischemia, decongestion of one or more nasal passages, reduction of at least one effect of an inflammatory disorder, increase in renal fluid flow, and alteration in the rate of fluid transport in the gastrointestinal tract. <CHEM>
申请公布号 AU7798894(A) 申请公布日期 1995.05.04
申请号 AU19940077988 申请日期 1994.09.19
申请人 ALLERGAN, INC. 发明人 JAMES A BURKE;MICHAEL E. GARST;LARRY A. WHEELER
分类号 C07D401/12;A61K31/495;A61K31/498;A61P1/12;A61P1/14;A61P9/00;A61P9/10;A61P9/12;A61P11/02;A61P13/02;A61P13/12;A61P15/00;A61P23/00;A61P23/02;A61P25/00;A61P25/02;A61P25/04;A61P27/16;A61P29/00;C07D403/12 主分类号 C07D401/12
代理机构 代理人
主权项
地址